Abstract:Huang-Lian-Jie-Du-Decotion (HLJDD), an important traditional Chinese medicine formula, has been used for various diseases in clinical practice, and thus has high potential to induce cytochrome P450 (CYP) isoenzymes/P-glycoprotein (P-gp) mediated herb-drug interactions (HDIs) with other co-administered drugs. The purpose of this study was to investigate the in vitro effects of multiple extracts including aqueous extracts, total flavonoids, iridoids, alkaloids from HLJDD on the activities of CYPs in rats (CYP1A2, CYP2C6, CYP2D2, CYP2E1 and CYP3A1) and P-gp, and then to predict potential interactions with co-administered drugs.The effects of the four extracts from HLJDD on the CYPs activity were evaluated in rat liver microsomes incubation system, and then determined by LC-MS/MS-based CYPs probe substrate assay. Caco-2 cell monolayer was used to investigate the effect of the four extracts on the efflux of Rhodamine 123 to evaluate their influences on P-gp activity.The results show that total flavonoids and alkaloids exibited strong inhibition on rat CYP isoenzymes activities. Total flavonoids exhibited different inhibitory effects on CYPs activities with an order of CYP3A1>CYP2C6>CYP2E1>CYP1A2>CYP2D2, and the values of IC₅₀ were 4.24, 8.16, 17.56, 19.03, 29.51 μg/mL, respectively. Total alkaloids possessed similar inhibition on CYPs and could strongly inhibit the activity of CYP2D2 (IC₅₀=2.38 μg/mL), CYP3A1 (IC₅₀=2.61 μg/mL), CYP2E1 (IC₅₀=22.35 μg/mL), CYP1A2 (IC₅₀=23.2 μg/mL) and CYP2C6 (IC₅₀=43.09 μg/mL). Moderate degree of inhibition on CYPs activities was observed in aqueous and total iridoids extracts. Results from transport assay revealed that total flavonoids and alkaloids exhibited significant inhibitory effect on P-gp activity as evidenced by strong inhibition on the efflux of Rhodamine-123 with IC₅₀ of 104.6 and 82.6 μg/mL. But aqueous extract showed weak and iridoids had negligible effect on P-gp activity.This study clearly demonstrated that total flavonoids and alkaloids from HLJDD can significantly inhibit the activities of CYPs and P-gp, which should be taken into consideration to predict any potential HDIs when HLJDD and its bioactive components are co-administered with other therapeutic drugs metabolized by CYPs or transported by P-gp.

Risk assessment of the inhibition of hydroxygenkwanin on human and rat cytochrome P450 by cocktail method

[Ginkgo Flavones in in Vitro Metabolism and Its Clinical Application].

Assessment of the inhibition risk of shikonin on cytochrome P450 via cocktail inhibition assay

Investigation of cytochrome P450 inhibitory properties of deoxyshikonin, a bioactive compound from Lithospermum erythrorhizon Sieb. et Zucc

Evaluation of the inhibition risk of shikonin on human and rat UDP-glucuronosyltransferases (UGT) through the cocktail approach

[Effects of Kaempferol and Quercetin on Cytochrome 450 Activities in Primarily Cultured Rat Hepatocytes].

Evaluation of the Inhibition Potential of Plumbagin Against Cytochrome P450 Using LC-MS/MS and Cocktail Approach.

In vitro inhibition of human liver cytochrome P450 enzymes by helicid

Inhibitory Effects of Phytochemicals on Metabolic Capabilities of CYP2D6()1 and CYP2D6()10 Using Cell-Based Models in Vitro.

Drug Interaction Study of Flavonoids Toward CYP3A4 and Their Quantitative Structure Activity Relationship (QSAR) Analysis for Predicting Potential Effects.

Flavonoids Inhibit Six Cytochrome P450 Enzymes from Human Liver Microsomes As Analyzed by LC-MS/MS Method

Inhibiton of cytochrome P450 isoenzymes and P-gp activity by multiple extracts of Huang-Lian-Jie-Du decoction.

In Vitro Inhibition of Six Cytochrome P450 Isoforms in Human Liver Microsomes by Qingkailing Injection and Its Two Active Components(Baicalin and Geniposide)

In Vitro Inhibition of Huanglianjiedu Decoction on 6 Cytochrome P450 Isoforms in Human Liver Microsomes

Cocktail Method: Effect Of The Bletilla Striata Extracts On Cytochromep450 Activity In Rat

Inhibitory effects of Hwang-Ryun-Hae-Dok-Tang on cytochrome P450 in human liver microsomes

Discovery and Characterization of the Key Constituents in Ginkgo biloba Leaf Extract With Potent Inhibitory Effects on Human UDP-Glucuronosyltransferase 1A1

A Novel System for Evaluating the Inhibition Effect of Drugs on Cytochrome P450 Enzymes in vitro Based on Human-Induced Hepatocytes (hiHeps)

[Glucuronidation and in Vitro Interaction of Ginkgo Flavonoids with Other Drugs].

Effect of a Ketohexokinase Inhibitor (PF-06835919) on In Vivo OATP1B Activity: Integrative Risk Assessment Using Endogenous Biomarker and a Probe Drug

Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs).